Latest Innovation News

Pure Resources advances its Reedy Creek project by exploring graphite potential and forging US partnerships to tap into thermal management and rare earth element technologies.

Midas Minerals has validated three significant gold trends spanning 9km at its Challa Project in Western Australia, using innovative detectORE™ pXRF technology. The company plans further infill sampling to define drill targets while advancing exploration preparations for its Otavi Copper Project in Namibia.

BPH Global Ltd (ASX, BP8) has initiated strategic discussions with Indonesia’s National Economic Council to deploy its innovative seaweed-based bioremediation solutions targeting pollution from nickel and coal mining operations.

Syntara Limited has initiated dosing in its Phase 1c SATELLITE trial for a novel topical treatment targeting keloid scars, marking a significant step in addressing a $3.5 billion global market. The study, led by Professor Fiona Wood, will evaluate safety and early efficacy over three months.

Prescient Therapeutics has extended its Share Purchase Plan closing date to 22 July 2025, aiming to raise up to A$7 million to advance its targeted cancer therapy PTX-100 through Phase 2 clinical trials.

Argent Minerals is fast-tracking diamond drilling and metallurgical testwork at its Kempfield Polymetallic Project to underpin a scoping study aimed at early cash flow and long-term development.

Janison Education Group has been appointed by the New Zealand Ministry of Education to deliver a new bilingual digital assessment platform for students in Years 3 to 10, marking a strategic expansion into the New Zealand education sector.

EBR Systems has received preliminary approval from the U.S. Centers for Medicare & Medicaid Services for outpatient reimbursement of its WiSE® CRT System, marking a major step toward broader hospital adoption.

Lumos Diagnostics has voluntarily suspended its ASX trading pending a market announcement about strategic agreements, signaling potential shifts in its business trajectory.

CleanSpace Holdings reports a robust 26% increase in FY25 revenue, driven by strong growth across Europe, North America, and APAC regions, underscoring its expanding footprint in industrial respiratory protection.

Ava Risk Group reports a 5% revenue increase and a positive EBITDA turnaround in FY25, underpinned by its advanced security technologies. The company eyes over $88 million in FY26 sales opportunities despite some project delays.

Ava Risk Group has suspended its dividend policy to reinvest capital into its growth strategy, signaling a shift in priorities for shareholders. The board will reassess this stance annually.